Recombinant Elongation factor 1-alpha

What is Elongation Factor 1-Alpha and what is its primary function in cellular systems?

Elongation Factor 1-Alpha (EF-1α) is a ubiquitous and highly conserved cytosolic protein found across eukaryotic organisms. Its primary function involves GTP-dependent binding and delivery of aminoacyl-tRNAs to the A site of ribosomes during protein biosynthesis . This process ensures correct amino acid incorporation during translation elongation. Beyond this canonical role, EF-1α participates in numerous biological processes including cell growth and proliferation, vesicular transmission, protein formation, development of mitotic apparatus, signal transduction, DNA replication/repair, and apoptosis . This multifunctionality makes EF-1α an essential component of cellular machinery beyond its translational role.

How are EF-1α isoforms distributed across different tissues and species?

In mammals, two main paralogs exist: eEF1A1 and eEF1A2, which share approximately 90% amino acid sequence homology . These isoforms demonstrate differential tissue distribution and functional properties:

The promoter regions of these isoforms show high sequence similarity, though eEF1A2 contains an additional 81 bp SV40 small antigen sequence at the 5′-end . In plants, such as tomato, EF-1α belongs to a small multigene family with 4-8 members, with higher expression in developing tissues that correlate with increased protein synthesis demands . Various parasites, including Haemonchus contortus, Trypanosoma brucei, and Giardia intestinalis, also express EF-1α variants that may play roles in host-parasite interactions .

What structural characteristics define recombinant EF-1α proteins?

Recombinant EF-1α proteins typically maintain the highly conserved structural features found in native EF-1α. These include:

• A three-domain architecture with domain I containing a Rossmann fold for GTP/GDP binding

• A molecular weight of approximately 50 kDa

• High sequence conservation across species, with mammalian EF-1α showing 75-78% similarity to EF-1α from lower eukaryotes and plants

• The presence of specific motifs for GTP binding and hydrolysis

When producing recombinant EF-1α, researchers often utilize expression systems such as pET32a vectors in E. coli BL21(DE3), which incorporate fusion tags to enhance solubility and facilitate purification . These recombinant proteins maintain functional characteristics of native EF-1α while providing experimental advantages for in vitro studies.

What are the optimal protocols for cloning and expressing recombinant EF-1α?

Successful production of recombinant EF-1α requires careful optimization at multiple experimental stages:

Gene Amplification and Cloning:

• Extract total RNA from appropriate tissue samples

• Synthesize cDNA using reverse transcriptase and oligo(dT) primers

• Amplify the EF-1α coding sequence using gene-specific primers with appropriate restriction sites

• Clone the amplified product into an expression vector (e.g., pET32a for bacterial expression)

• Verify the sequence integrity through DNA sequencing

Protein Expression:

• Transform the validated construct into E. coli BL21(DE3) or other suitable expression hosts

• Grow transformed bacteria to mid-log phase (OD₆₀₀ = 0.6-0.8)

• Induce protein expression with IPTG (typically 1mM) at 37°C for 4-6 hours

• For improved solubility, consider lower induction temperatures (16-25°C) overnight

• Harvest cells by centrifugation and lyse using appropriate methods (sonication or mechanical disruption)

Protein Purification:

• Clarify the lysate by high-speed centrifugation

• Apply the supernatant to nickel affinity chromatography for His-tagged proteins

• Wash extensively to remove non-specifically bound proteins

• Elute with an imidazole gradient

• Consider additional purification steps such as ion exchange or size exclusion chromatography

• Dialyze against an appropriate storage buffer containing glycerol to maintain stability

For parasite-derived EF-1α such as HcEF-1α, these methods have yielded functional recombinant protein suitable for immunological and biochemical studies .

How can the binding of recombinant EF-1α to cellular components be assessed?

Multiple complementary approaches can be employed to characterize recombinant EF-1α interactions with cellular components:

Immunofluorescence Assay (IFA):

• Incubate target cells (e.g., PBMCs) with recombinant EF-1α (10 μg/mL) in appropriate conditions (37°C, 5% CO₂, 2 hours)

• Wash cells to remove unbound protein

• Fix cells with paraformaldehyde (4%)

• Permeabilize if investigating intracellular binding

• Block with bovine serum albumin (5%)

• Probe with primary antibodies against recombinant EF-1α

• Detect using fluorophore-conjugated secondary antibodies

• Analyze using confocal microscopy to determine binding patterns and subcellular localization

Flow Cytometry Analysis:

• Incubate cells with fluorescently labeled recombinant EF-1α

• Wash to remove unbound protein

• Analyze binding using flow cytometry to quantify:

  • Percentage of positive cells

  • Mean fluorescence intensity

  • Binding kinetics through time-course experiments

Co-immunoprecipitation:

• Incubate cell lysates with recombinant EF-1α

• Precipitate using antibodies against EF-1α or potential binding partners

• Analyze precipitated complexes by Western blotting

• Identify novel interactions through mass spectrometry analysis

These methods have successfully demonstrated that recombinant HcEF-1α binds to the surface of goat PBMCs, providing insight into host-parasite interactions .

What are the recommended approaches for evaluating recombinant EF-1α effects on immune cell functions?

A comprehensive assessment of recombinant EF-1α effects on immune cell functions requires multiple experimental approaches:

Cytokine Production Analysis:

• Incubate immune cells (e.g., PBMCs) with varying concentrations of recombinant EF-1α (10-80 μg/mL)

• Include appropriate controls (PBS and vector protein controls)

• Culture for 24-72 hours under standard conditions (37°C, 5% CO₂)

• Collect supernatants for protein detection or cell pellets for gene expression analysis

• Quantify cytokine levels using ELISA or RT-qPCR with cytokine-specific primers

For RT-qPCR analysis, primers can be designed as follows:

Cell Proliferation Assessment:

• Seed cells in 96-well plates (1 × 10⁶ cells/mL)

• Activate with ConA (10 μg/mL) if appropriate

• Add different concentrations of recombinant EF-1α and controls

• Incubate for 72 hours at 37°C with 5% CO₂

• Add cell counting reagent (e.g., CCK-8) 4 hours before endpoint

• Measure absorbance at 450 nm using a microplate reader

Cell Migration Evaluation:

• Use Transwell migration chambers

• Place recombinant EF-1α in the lower chamber as a potential chemoattractant

• Add cells to the upper chamber

• Allow migration for 4-6 hours

• Count migrated cells using microscopy or flow cytometry

• Calculate migration index relative to control conditions

Surface Molecule Expression Analysis:

• Incubate cells with recombinant EF-1α

• Stain with fluorescently labeled antibodies against surface molecules (e.g., MHC-I, MHC-II)

• Analyze using flow cytometry

• Calculate percentage of positive cells and mean fluorescence intensity

Studies with recombinant HcEF-1α have demonstrated significant modulatory effects on goat PBMC functions, including altered cytokine production, increased cell migration and proliferation, and modulated MHC-II expression .

How can recombinant EF-1α be utilized to investigate host-parasite interactions?

Recombinant EF-1α derived from parasites serves as a valuable tool for dissecting complex host-parasite interactions:

Immune Modulation Studies:
Recombinant parasite EF-1α (e.g., HcEF-1α from Haemonchus contortus) has been shown to modulate host immune responses in several ways:

• Altering cytokine production profiles (increasing IL-4, TGF-β1, IFN-γ, and IL-17, while decreasing IL-10)

• Enhancing cell migration and proliferation

• Increasing cell apoptosis

• Decreasing nitric oxide production

• Modulating MHC-II expression

These immunomodulatory effects provide insights into how parasites may evade host immune responses to establish successful infections.

Binding Partner Identification:

• Use recombinant parasite EF-1α as bait in pull-down assays with host cell lysates

• Identify binding partners through mass spectrometry

• Validate interactions using co-immunoprecipitation and surface plasmon resonance

• Map interaction domains through truncation mutants

Vaccine Development Evaluation:
As EF-1α is recognized by sera from infected hosts, its potential as a vaccine candidate can be assessed by:

• Immunization trials in animal models

• Analysis of protective antibody responses

• Evaluation of cell-mediated immunity

• Challenge infections to assess protective efficacy

Structural and Functional Comparison:
Compare parasite and host EF-1α to identify:

• Unique structural features that could be targeted for therapeutic intervention

• Differential binding properties to host molecules

• Species-specific functional adaptations

These applications collectively enhance our understanding of host-parasite relationships and may reveal new intervention strategies for parasitic diseases.

What is the role of EF-1α in viral replication and how can recombinant EF-1α be used to study these interactions?

EF-1α plays significant roles in viral replication, particularly for HIV-1 and other retroviruses:

Interaction with Viral Proteins:
Research has demonstrated that EF-1α interacts with HIV-1 Gag polyprotein, particularly through:

• The matrix (MA) domain of Gag

• The nucleocapsid (NC) domain, which provides a second, independent EF-1α-binding site

These interactions can be studied using recombinant EF-1α through:

• Pull-down assays and co-immunoprecipitation

• Surface plasmon resonance to determine binding kinetics

• Yeast two-hybrid screening to identify specific interaction domains

Effects on Viral Translation:
The interaction between HIV-1 MA and EF-1α impairs translation in vitro, suggesting a regulatory mechanism where:

• Accumulated Gag proteins bind EF-1α

• This binding inhibits normal translation functions

• Inhibition may help release viral RNA from polysomes

• The released RNA becomes available for packaging into virions

RNA-Mediated Interactions:
Evidence suggests that the Gag-EF-1α interaction is mediated by RNA:

• Basic residues in MA and NC are required for binding to EF-1α

• RNase treatment disrupts the interaction

• Gag mutants with reduced EF-1α-binding show impaired tRNA association

Virion Incorporation:
EF-1α is specifically incorporated into HIV-1 virion membranes where it:

• Undergoes viral protease-mediated cleavage

• Is protected from digestion by exogenously added subtilisin

• Shows specificity for lentiviral virions (does not associate with non-lentiviral MAs or Moloney murine leukemia virus virions)

These findings highlight the importance of EF-1α in viral replication and potential antiviral targets.

How does recombinant EF-1α expression differ between developmental stages and tissues?

Understanding differential expression patterns of EF-1α provides insights into its diverse biological roles:

Developmental Stage Variation:
In plants like tomato, EF-1α shows developmental regulation:

• Higher EF-1α mRNA levels are found in developing tissues (young leaves and green fruit)

• Lower expression occurs in older tissues

• This pattern correlates with increased protein synthesis demands during development

Tissue-Specific Expression:
In mammals, the two EF-1α isoforms show distinct tissue-specific patterns:

• eEF1A1 is ubiquitously expressed in most tissues including brain, placenta, lung, liver, kidney, and pancreas

• eEF1A2 expression is restricted to adult neuronal and muscle cells (brain, heart, and skeletal muscle)

Methodological Approaches for Studying Expression Patterns:

• Quantitative RT-PCR using isoform-specific primers to distinguish between EF-1α variants

• In situ hybridization for spatial localization of mRNA in tissues

• Western blotting with isoform-specific antibodies for protein detection

• Immunohistochemistry for cellular and subcellular localization

• Promoter-reporter constructs to study transcriptional regulation

Functional Implications:
The differential expression of EF-1α isoforms suggests specialized roles:

• eEF1A1, but not eEF1A2, induces HSP70 during heat shock, indicating stress-specific functions

• Tissue-specific expression of eEF1A2 in terminally differentiated cells suggests roles beyond protein synthesis

• Developmental regulation in plants correlates with growth and differentiation processes

Understanding these expression patterns provides context for interpreting experimental results with recombinant EF-1α and designing targeted interventions.

What are common challenges in producing functional recombinant EF-1α and how can they be addressed?

Producing functional recombinant EF-1α presents several challenges that can be systematically addressed:

Protein Solubility Issues:

Maintaining Functional Activity:

Endotoxin Contamination:
For immunological studies, bacterial endotoxins can confound results:

• Use endotoxin removal columns or polymyxin B during purification

• Validate endotoxin levels using Limulus Amebocyte Lysate (LAL) assay

• Consider non-bacterial expression systems for critical applications

Tag Interference:
Fusion tags may interfere with protein function:

• Compare tagged and tag-cleaved versions of the protein

• Use small, unobtrusive tags when possible

• Place tags at termini least likely to affect function based on structural information

These strategies have been successfully implemented to produce functional recombinant HcEF-1α suitable for immune modulation studies .

How can researchers verify the structural and functional integrity of recombinant EF-1α?

Comprehensive validation of recombinant EF-1α requires multiple complementary approaches:

Structural Validation:

• SDS-PAGE and Western blotting to confirm molecular weight and immunoreactivity

• Circular dichroism (CD) spectroscopy to assess secondary structure elements

• Size exclusion chromatography to verify monomeric state and absence of aggregation

• Mass spectrometry for accurate mass determination and identification of post-translational modifications

Immunological Verification:

• Confirm recognition by antibodies against native EF-1α

• For parasite EF-1α, verify recognition by sera from infected hosts

• Analyze cross-reactivity with related EF-1α proteins from different species

Functional Validation:

• GTP binding assays using fluorescent GTP analogs or isothermal titration calorimetry

• GTPase activity measurement using malachite green phosphate assay

• Aminoacyl-tRNA binding assays using fluorescently labeled tRNAs

• In vitro translation assays to confirm translational elongation activity

Application-Specific Validation:
For parasite EF-1α like HcEF-1α, verify:

• Binding to host immune cells through immunofluorescence or flow cytometry

• Immunomodulatory effects on cytokine production, cell proliferation, and other immune parameters

• Specificity of these effects compared to control proteins

These validation approaches ensure that experimental observations truly reflect the biological properties of EF-1α rather than artifacts of recombinant production.

What strategies are effective for studying differential functions of EF-1α isoforms?

To elucidate the distinct functions of EF-1α isoforms (such as eEF1A1 vs. eEF1A2 in mammals), researchers should employ several strategic approaches:

Isoform-Specific Expression Systems:

• Generate recombinant constructs for each isoform with identical tags

• Ensure equivalent expression and purification methods for direct comparison

• Validate isoform identity by mass spectrometry or isoform-specific antibodies

Domain Mapping and Mutagenesis:

• Create chimeric constructs with domains exchanged between isoforms

• Introduce specific mutations at divergent amino acid positions

• Analyze which regions confer isoform-specific functions

Comparative Binding Partner Analysis:

• Perform isoform-specific pull-downs followed by mass spectrometry

• Use yeast two-hybrid screens with different isoforms as bait

• Validate key differential interactions by co-immunoprecipitation

Differential Expression Analysis:

• Compare expression patterns across tissues and developmental stages

• Correlate expression with specific cellular functions

• Analyze promoter activities to understand transcriptional regulation

Functional Complementation Studies:

• Express individual isoforms in cells where endogenous EF-1α has been depleted

• Assess rescue of various cellular functions

• Compare responses to different cellular stresses (e.g., heat shock, oxidative stress)

These approaches enable systematic characterization of isoform-specific roles, providing insights into the evolutionary and physiological significance of EF-1α diversity.

What statistical approaches are recommended for analyzing recombinant EF-1α experimental data?

Experimental Design Considerations:

• Include at least three independent biological replicates

• Use appropriate positive controls (e.g., ConA for lymphocyte stimulation) and negative controls (PBS, vector protein)

• Test multiple concentration points (e.g., 10, 20, 40, and 80 μg/mL) for dose-response relationships

Statistical Tests for Common Experimental Scenarios:

Power Analysis and Sample Size:

• Determine minimum sample size needed for desired statistical power

• Consider effect size in power calculations

• Report confidence intervals alongside p-values

• Apply appropriate corrections for multiple comparisons

Data Visualization Strategies:

These statistical approaches have been successfully applied in studies of recombinant HcEF-1α effects on immune cells, revealing significant modulatory effects on cytokine production, cell proliferation, and other immune parameters .

How should researchers interpret contradictory findings regarding recombinant EF-1α functions?

When faced with contradictory findings regarding recombinant EF-1α functions, researchers should adopt a systematic interpretative framework:

Source and Preparation Differences:

• Compare the origin of EF-1α (species, isoform, tissue source)

• Evaluate expression systems used (bacterial, yeast, mammalian cells)

• Assess purification methods and potential effects on protein conformation

• Consider the presence/absence of fusion tags and their potential interference

Experimental Context Variations:

• Compare cell types or model organisms used

• Evaluate buffer compositions and reaction conditions

• Consider physiological relevance of protein concentrations

• Assess the presence of cofactors or binding partners

Methodological Considerations:

• Compare sensitivity and specificity of detection methods

• Evaluate the validity of readout systems

• Consider potential artifacts from experimental manipulations

• Assess the statistical robustness of contradictory findings

Resolution Approaches:

• Design experiments that directly address contradictions

• Perform side-by-side comparisons under identical conditions

• Use multiple, complementary techniques to validate findings

• Consider collaborative studies between laboratories reporting contradictory results

This systematic approach helps distinguish genuine biological complexity from technical artifacts and leads to a more nuanced understanding of EF-1α's multifunctional nature across different biological contexts.

What bioinformatic resources are most valuable for analyzing EF-1α sequence, structure, and function relationships?

Comprehensive analysis of EF-1α requires integration of multiple bioinformatic tools and databases:

Sequence Analysis Tools:

• BLAST and PSI-BLAST for sequence similarity searches

• Clustal Omega or MUSCLE for multiple sequence alignments

• MEGA or PHYLIP for phylogenetic analysis

• SMART, Pfam, and InterPro for domain identification

• ConSurf for evolutionary conservation mapping

Structural Analysis Resources:

• Protein Data Bank (PDB) for experimental structures

• SWISS-MODEL or I-TASSER for homology modeling

• PyMOL or UCSF Chimera for structure visualization and analysis

• FTMap for binding site prediction

• PROCHECK or MolProbity for structure validation

Functional Prediction Tools:

• STRING for protein-protein interaction networks

• NetPhos or GPS for phosphorylation site prediction

• ProtParam for physicochemical property prediction

• PredictProtein for functional site prediction

Specialized Databases:

• UniProt for curated protein information

• Ensembl or NCBI Gene for genomic context

• KEGG or Reactome for pathway information

By integrating these resources, researchers can gain comprehensive insights into EF-1α's evolutionary history, structural features, and functional mechanisms, facilitating hypothesis generation and experimental design.